Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD19+ B cell values predict the increase of anti-SARS CoV2 antibodies in fingolimod-treated and COVID-19-vaccinated patients with multiple sclerosis.
Schiavetti I, Barcellini L, Lapucci C, Tazza F, Cellerino M, Capello E, Franciotta D, Inglese M, Sormani MP, Uccelli A, Laroni A. Schiavetti I, et al. Among authors: capello e. Mult Scler Relat Disord. 2023 Feb;70:104494. doi: 10.1016/j.msard.2022.104494. Epub 2022 Dec 30. Mult Scler Relat Disord. 2023. PMID: 36603292 Free PMC article.
Contribution of Rare and Low-Frequency Variants to Multiple Sclerosis Susceptibility in the Italian Continental Population.
Clarelli F, Barizzone N, Mangano E, Zuccalà M, Basagni C, Anand S, Sorosina M, Mascia E, Santoro S; PROGEMUS; PROGRESSO; Guerini FR, Virgilio E, Gallo A, Pizzino A, Comi C, Martinelli V, Comi G, De Bellis G, Leone M, Filippi M, Esposito F, Bordoni R, Martinelli Boneschi F, D'Alfonso S. Clarelli F, et al. Front Genet. 2022 Jan 3;12:800262. doi: 10.3389/fgene.2021.800262. eCollection 2021. Front Genet. 2022. PMID: 35047017 Free PMC article.
Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis.
Cellerino M, Boffa G, Lapucci C, Tazza F, Sbragia E, Mancuso E, Bruschi N, Minguzzi S, Ivaldi F, Poirè I, Laroni A, Mancardi G, Capello E, Uccelli A, Novi G, Inglese M. Cellerino M, et al. Among authors: capello e. Neurotherapeutics. 2021 Oct;18(4):2579-2588. doi: 10.1007/s13311-021-01104-8. Epub 2021 Sep 22. Neurotherapeutics. 2021. PMID: 34553320 Free PMC article.
Long-term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis.
Boffa G, Massacesi L, Inglese M, Mariottini A, Capobianco M, Moiola L, Amato MP, Cottone S, Gualandi F, De Gobbi M, Greco R, Scimè R, Frau J, Zimatore GB, Bertolotto A, Comi G, Uccelli A, Signori A, Angelucci E, Innocenti C, Ciceri F, Repice AM, Sormani MP, Saccardi R, Mancardi G; Italian BMT-MS Study Group. Boffa G, et al. Neurology. 2021 Feb 22;96(8):e1215-e1226. doi: 10.1212/WNL.0000000000011461. Neurology. 2021. PMID: 33472915 Free article.
CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS.
Capodivento G, De Michelis C, Carpo M, Fancellu R, Schirinzi E, Severi D, Visigalli D, Franciotta D, Manganelli F, Siciliano G, Beronio A, Capello E, Lanteri P, Nobile-Orazio E, Schenone A, Benedetti L, Nobbio L. Capodivento G, et al. Among authors: capello e. J Neurol Neurosurg Psychiatry. 2021 Mar;92(3):303-310. doi: 10.1136/jnnp-2020-324445. Epub 2020 Oct 22. J Neurol Neurosurg Psychiatry. 2021. PMID: 33093191 Free PMC article.
COVID-19-related and not related Guillain-Barré syndromes share the same management pitfalls during lock down: The experience of Liguria region in Italy.
Garnero M, Del Sette M, Assini A, Beronio A, Capello E, Cabona C, Reni L, Serrati C, Bandini F, Granata A, Pesce G, Mancardi GL, Uccelli A, Schenone A, Benedetti L. Garnero M, et al. Among authors: capello e. J Neurol Sci. 2020 Nov 15;418:117114. doi: 10.1016/j.jns.2020.117114. Epub 2020 Sep 2. J Neurol Sci. 2020. PMID: 32947089 Free PMC article.
99 results